United States Entecavir Market Report 2017

August 2017 | 97 pages | ID: U6E3B4B6B03EN
QYResearch

Abstracts

In this report, the United States Entecavir market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Entecavir in these regions, from 2012 to 2022 (forecast).

United States Entecavir market competition by top manufacturers/players, with Entecavir sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Bristol-Myers Squibb
• Teva Pharmaceuticals USA
• Hetero Labs
• Aurobindo Pharma
• CTTQ PHARMA
• Qingfeng Pharmaceutical Group
• Suzhou Dongrui Pharmacy

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Tablets
• Oral Solution
• Capsule

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Entecavir for each application, including

• Chronic Hepatitis B Virus Infection
• HIV Patients Infected with HBV

Contents

United States Entecavir Market Report 2017

1 ENTECAVIR OVERVIEW

1.1 Product Overview and Scope of Entecavir
1.2 Classification of Entecavir by Product Category
  1.2.1 United States Entecavir Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Entecavir Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Tablets
  1.2.4 Oral Solution
  1.2.5 Capsule
1.3 United States Entecavir Market by Application/End Users
  1.3.1 United States Entecavir Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Chronic Hepatitis B Virus Infection
  1.3.3 HIV Patients Infected with HBV
1.4 United States Entecavir Market by Region
  1.4.1 United States Entecavir Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Entecavir Status and Prospect (2012-2022)
  1.4.3 Southwest Entecavir Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Entecavir Status and Prospect (2012-2022)
  1.4.5 New England Entecavir Status and Prospect (2012-2022)
  1.4.6 The South Entecavir Status and Prospect (2012-2022)
  1.4.7 The Midwest Entecavir Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Entecavir (2012-2022)
  1.5.1 United States Entecavir Sales and Growth Rate (2012-2022)
  1.5.2 United States Entecavir Revenue and Growth Rate (2012-2022)

2 UNITED STATES ENTECAVIR MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Entecavir Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Entecavir Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Entecavir Average Price by Players/Suppliers (2012-2017)
2.4 United States Entecavir Market Competitive Situation and Trends
  2.4.1 United States Entecavir Market Concentration Rate
  2.4.2 United States Entecavir Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Entecavir Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES ENTECAVIR SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Entecavir Sales and Market Share by Region (2012-2017)
3.2 United States Entecavir Revenue and Market Share by Region (2012-2017)
3.3 United States Entecavir Price by Region (2012-2017)

4 UNITED STATES ENTECAVIR SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Entecavir Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Entecavir Revenue and Market Share by Type (2012-2017)
4.3 United States Entecavir Price by Type (2012-2017)
4.4 United States Entecavir Sales Growth Rate by Type (2012-2017)

5 UNITED STATES ENTECAVIR SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Entecavir Sales and Market Share by Application (2012-2017)
5.2 United States Entecavir Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES ENTECAVIR PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Bristol-Myers Squibb
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Entecavir Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Bristol-Myers Squibb Entecavir Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Teva Pharmaceuticals USA
  6.2.2 Entecavir Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Teva Pharmaceuticals USA Entecavir Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Hetero Labs
  6.3.2 Entecavir Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Hetero Labs Entecavir Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Aurobindo Pharma
  6.4.2 Entecavir Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Aurobindo Pharma Entecavir Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 CTTQ PHARMA
  6.5.2 Entecavir Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 CTTQ PHARMA Entecavir Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Qingfeng Pharmaceutical Group
  6.6.2 Entecavir Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Qingfeng Pharmaceutical Group Entecavir Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Suzhou Dongrui Pharmacy
  6.7.2 Entecavir Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Suzhou Dongrui Pharmacy Entecavir Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview

7 ENTECAVIR MANUFACTURING COST ANALYSIS

7.1 Entecavir Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Entecavir

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Entecavir Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Entecavir Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES ENTECAVIR MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Entecavir Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Entecavir Sales Volume Forecast by Type (2017-2022)
11.3 United States Entecavir Sales Volume Forecast by Application (2017-2022)
11.4 United States Entecavir Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Entecavir
Figure United States Entecavir Market Size (K Units) by Type (2012-2022)
Figure United States Entecavir Sales Volume Market Share by Type (Product Category) in 2016
Figure Tablets Product Picture
Figure Oral Solution Product Picture
Figure Capsule Product Picture
Figure United States Entecavir Market Size (K Units) by Application (2012-2022)
Figure United States Sales Market Share of Entecavir by Application in 2016
Figure Chronic Hepatitis B Virus Infection Examples
Figure HIV Patients Infected with HBV Examples
Figure United States Entecavir Market Size (Million USD) by Region (2012-2022)
Figure The West Entecavir Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Entecavir Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Entecavir Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Entecavir Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Entecavir Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Entecavir Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Entecavir Sales (K Units) and Growth Rate (2012-2022)
Figure United States Entecavir Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Entecavir Market Major Players Product Sales Volume (K Units) (2012-2017)
Table United States Entecavir Sales (K Units) of Key Players/Suppliers (2012-2017)
Table United States Entecavir Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Entecavir Sales Share by Players/Suppliers
Figure 2017 United States Entecavir Sales Share by Players/Suppliers
Figure United States Entecavir Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Entecavir Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Entecavir Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Entecavir Revenue Share by Players/Suppliers
Figure 2017 United States Entecavir Revenue Share by Players/Suppliers
Table United States Market Entecavir Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)
Figure United States Market Entecavir Average Price (USD/Unit) of Key Players/Suppliers in 2016
Figure United States Entecavir Market Share of Top 3 Players/Suppliers
Figure United States Entecavir Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Entecavir Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Entecavir Product Category
Table United States Entecavir Sales (K Units) by Region (2012-2017)
Table United States Entecavir Sales Share by Region (2012-2017)
Figure United States Entecavir Sales Share by Region (2012-2017)
Figure United States Entecavir Sales Market Share by Region in 2016
Table United States Entecavir Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Entecavir Revenue Share by Region (2012-2017)
Figure United States Entecavir Revenue Market Share by Region (2012-2017)
Figure United States Entecavir Revenue Market Share by Region in 2016
Table United States Entecavir Price (USD/Unit) by Region (2012-2017)
Table United States Entecavir Sales (K Units) by Type (2012-2017)
Table United States Entecavir Sales Share by Type (2012-2017)
Figure United States Entecavir Sales Share by Type (2012-2017)
Figure United States Entecavir Sales Market Share by Type in 2016
Table United States Entecavir Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Entecavir Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Entecavir by Type (2012-2017)
Figure Revenue Market Share of Entecavir by Type in 2016
Table United States Entecavir Price (USD/Unit) by Types (2012-2017)
Figure United States Entecavir Sales Growth Rate by Type (2012-2017)
Table United States Entecavir Sales (K Units) by Application (2012-2017)
Table United States Entecavir Sales Market Share by Application (2012-2017)
Figure United States Entecavir Sales Market Share by Application (2012-2017)
Figure United States Entecavir Sales Market Share by Application in 2016
Table United States Entecavir Sales Growth Rate by Application (2012-2017)
Figure United States Entecavir Sales Growth Rate by Application (2012-2017)
Table Bristol-Myers Squibb Basic Information List
Table Bristol-Myers Squibb Entecavir Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Bristol-Myers Squibb Entecavir Sales Growth Rate (2012-2017)
Figure Bristol-Myers Squibb Entecavir Sales Market Share in United States (2012-2017)
Figure Bristol-Myers Squibb Entecavir Revenue Market Share in United States (2012-2017)
Table Teva Pharmaceuticals USA Basic Information List
Table Teva Pharmaceuticals USA Entecavir Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Teva Pharmaceuticals USA Entecavir Sales Growth Rate (2012-2017)
Figure Teva Pharmaceuticals USA Entecavir Sales Market Share in United States (2012-2017)
Figure Teva Pharmaceuticals USA Entecavir Revenue Market Share in United States (2012-2017)
Table Hetero Labs Basic Information List
Table Hetero Labs Entecavir Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Hetero Labs Entecavir Sales Growth Rate (2012-2017)
Figure Hetero Labs Entecavir Sales Market Share in United States (2012-2017)
Figure Hetero Labs Entecavir Revenue Market Share in United States (2012-2017)
Table Aurobindo Pharma Basic Information List
Table Aurobindo Pharma Entecavir Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Aurobindo Pharma Entecavir Sales Growth Rate (2012-2017)
Figure Aurobindo Pharma Entecavir Sales Market Share in United States (2012-2017)
Figure Aurobindo Pharma Entecavir Revenue Market Share in United States (2012-2017)
Table CTTQ PHARMA Basic Information List
Table CTTQ PHARMA Entecavir Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure CTTQ PHARMA Entecavir Sales Growth Rate (2012-2017)
Figure CTTQ PHARMA Entecavir Sales Market Share in United States (2012-2017)
Figure CTTQ PHARMA Entecavir Revenue Market Share in United States (2012-2017)
Table Qingfeng Pharmaceutical Group Basic Information List
Table Qingfeng Pharmaceutical Group Entecavir Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Qingfeng Pharmaceutical Group Entecavir Sales Growth Rate (2012-2017)
Figure Qingfeng Pharmaceutical Group Entecavir Sales Market Share in United States (2012-2017)
Figure Qingfeng Pharmaceutical Group Entecavir Revenue Market Share in United States (2012-2017)
Table Suzhou Dongrui Pharmacy Basic Information List
Table Suzhou Dongrui Pharmacy Entecavir Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Suzhou Dongrui Pharmacy Entecavir Sales Growth Rate (2012-2017)
Figure Suzhou Dongrui Pharmacy Entecavir Sales Market Share in United States (2012-2017)
Figure Suzhou Dongrui Pharmacy Entecavir Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Entecavir
Figure Manufacturing Process Analysis of Entecavir
Figure Entecavir Industrial Chain Analysis
Table Raw Materials Sources of Entecavir Major Players/Suppliers in 2016
Table Major Buyers of Entecavir
Table Distributors/Traders List
Figure United States Entecavir Sales Volume (K Units) and Growth Rate Forecast (2017-2022)
Figure United States Entecavir Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Entecavir Price (USD/Unit) Trend Forecast (2017-2022)
Table United States Entecavir Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Entecavir Sales Volume (K Units) Forecast by Type (2017-2022)
Figure United States Entecavir Sales Volume (K Units) Forecast by Type in 2022
Table United States Entecavir Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Entecavir Sales Volume (K Units) Forecast by Application (2017-2022)
Figure United States Entecavir Sales Volume (K Units) Forecast by Application in 2022
Table United States Entecavir Sales Volume (K Units) Forecast by Region (2017-2022)
Table United States Entecavir Sales Volume Share Forecast by Region (2017-2022)
Figure United States Entecavir Sales Volume Share Forecast by Region (2017-2022)
Figure United States Entecavir Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources